Gapping down
In reaction to disappointing earnings/guidance: WDFC -5.4%, ZUMZ -0.5%
Other news: ANTH -8.2% (proposed offering of common stock), BGMD -5.9% (announced a one-for-four reverse stock split), SSRI -0.3% (reported it delivered ~48,700 ounces of gold in Q2; raised FY15 production guidance)
Analyst comments: DNKN -1.5% (downgraded to Neutral at Goldman), PNK -1.5% (downgraded to Neutral from Positive at Susquehanna), SHAK -0.9% (downgraded to Sell at Goldman
)
In reaction to disappointing earnings/guidance: WDFC -5.4%, ZUMZ -0.5%
Other news: ANTH -8.2% (proposed offering of common stock), BGMD -5.9% (announced a one-for-four reverse stock split), SSRI -0.3% (reported it delivered ~48,700 ounces of gold in Q2; raised FY15 production guidance)
Analyst comments: DNKN -1.5% (downgraded to Neutral at Goldman), PNK -1.5% (downgraded to Neutral from Positive at Susquehanna), SHAK -0.9% (downgraded to Sell at Goldman
)